Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and the WWE and Encourages Investors to Contact the Firm
Retrieved on:
Thursday, July 21, 2022
Hush, Death, Sale, The Wall Street Journal, United, GLOBE, Documentation, WWE, Health Insurance Portability and Accountability Act, Rollins, U.S. Securities and Exchange Commission, HIPAA, Female, CEO, NYSE, SEC, CORT, Board, Period. End of Sentence., Corcept Therapeutics, NASDAQ, Accountability Act, Civilian Complaint Review Board, News, Review, Company, P.C, Record, Annual report, District, McMahon, Online gambling, Audit, Animal, Enochian
Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
Key Points:
- Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
- On this news, Enochians stock fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022.
- Dr. Gumrukcu sold 253,493 shares of Enochian stock on May 18, 2022, for a total value of over $2 million.
- For more information on the WWE investigation go to: https://bespc.com/cases/WWE
About Bragar Eagel & Squire, P.C.